Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study Using DNA Samples From Patients Who Participated in Previous Topiramate Obesity and Type 2 Diabetes Studies
This study has been completed.
Study NCT00304603   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: March 17, 2006   Last Updated: March 21, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 2
Obesity
Additional conditions recognized in this trial
Diabetes Mellitus
More general conditions related to this trial
Body Weight
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Nutrition Disorders
Overnutrition
Overweight
Signs and Symptoms
Additional drug interventions recognized in this trial
Topiramate
More general drug interventions related to this trial
Anti-Obesity Agents
Anticonvulsants
Central Nervous System Agents
Neuroprotective Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services